Status:
UNKNOWN
Evaluation on Efficacy of Total Artificial Disc Replacement (TDR) of Cervical Spondylosis
Lead Sponsor:
Peking University People's Hospital
Conditions:
Cervical Spondylosis
Eligibility:
All Genders
20-60 years
Brief Summary
To evaluate the efficacy of 3 different types of cervical disc prosthesis (Prodisc-C, Mobi-C and Prestige-LP) in the treatment of cervical spondylosis.
Detailed Description
A cohort, retrospective analysis will be performed of 150 patients who were in implementation of artificial disc replacement in our department from 2008 to 2012 and accepted a regular postoperatively ...
Eligibility Criteria
Inclusion
- Patients was diagnosed as cervical spondylosis based on imaging and symptomology;
- patients were purely underwent TDR within the three kinds of prosthesis;
- the range of participants is from 20-65 years;
- conservative treatment of 6 months is invalid;
- never had cervical operations.
Exclusion
- Patients suffered from cervical trauma or congenital malformations;
- non-artificial cervical disc replacement or hybrid surgery;
- ones who refused to be followed up.
Key Trial Info
Start Date :
February 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2018
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT03364816
Start Date
February 1 2018
End Date
December 31 2018
Last Update
December 7 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.